Page last updated: 2024-10-24

butenafine and Disease Models, Animal

butenafine has been researched along with Disease Models, Animal in 3 studies

butenafine: studied on experimental dermatophytosis
butenafine : Trimethylamine in which hydrogen atoms attached to different methyl groups are substituted by 1-naphthyl and 4-tert-butylphenyl groups. It is an inhibitor of squalene epoxidase, an enzyme responsible for the creation of sterols needed in fungal cell membranes, and is used as its hydrochloride salt for treatment of dermatological fungal infections.

Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.

Research Excerpts

ExcerptRelevanceReference
"The effectiveness of topical terbinafine (TBF) to tinea pedis was evaluated an animal model in which guinea pigs were experimentally infected through their planta pedis with Trichophyton mentagrophytes, then a 1% TBF or butenafine (BTF) cream was administered topically once daily for 4 consecutive weeks."7.69[A study on effectiveness of treatment and prevention of relapse using topical administration of terbinafine in a guinea pig model for tinea pedis]. ( Kudoh, M; Uchida, K; Yamaguchi, H, 1994)
"Butenafine is a novel antifungal agent of the class of benzylamines."5.28Topical treatment with butenafine significantly lowers relapse rate in an interdigital tinea pedis model in guinea pigs. ( Arika, T; Yamaguchi, H; Yokoo, M, 1992)
"The effectiveness of topical terbinafine (TBF) to tinea pedis was evaluated an animal model in which guinea pigs were experimentally infected through their planta pedis with Trichophyton mentagrophytes, then a 1% TBF or butenafine (BTF) cream was administered topically once daily for 4 consecutive weeks."3.69[A study on effectiveness of treatment and prevention of relapse using topical administration of terbinafine in a guinea pig model for tinea pedis]. ( Kudoh, M; Uchida, K; Yamaguchi, H, 1994)
"Butenafine is a novel antifungal agent of the class of benzylamines."1.28Topical treatment with butenafine significantly lowers relapse rate in an interdigital tinea pedis model in guinea pigs. ( Arika, T; Yamaguchi, H; Yokoo, M, 1992)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Abrams, RPM1
Yasgar, A1
Teramoto, T1
Lee, MH1
Dorjsuren, D1
Eastman, RT1
Malik, N1
Zakharov, AV1
Li, W1
Bachani, M1
Brimacombe, K1
Steiner, JP1
Hall, MD1
Balasubramanian, A1
Jadhav, A1
Padmanabhan, R1
Simeonov, A1
Nath, A1
Uchida, K1
Kudoh, M1
Yamaguchi, H2
Arika, T1
Yokoo, M1

Other Studies

3 other studies available for butenafine and Disease Models, Animal

ArticleYear
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

    Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr

2020
[A study on effectiveness of treatment and prevention of relapse using topical administration of terbinafine in a guinea pig model for tinea pedis].
    The Japanese journal of antibiotics, 1994, Volume: 47, Issue:10

    Topics: Administration, Topical; Animals; Antifungal Agents; Benzylamines; Disease Models, Animal; Drug Eval

1994
Topical treatment with butenafine significantly lowers relapse rate in an interdigital tinea pedis model in guinea pigs.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:11

    Topics: Administration, Topical; Animals; Antifungal Agents; Benzylamines; Disease Models, Animal; Guinea Pi

1992